Tag: Johnson & Johnson

J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin

Johnson & Johnson Announces EC Approval for Janssen’s Preventive Ebola Vaccine

FDA OK’s for Johnson & Johnson’s SIRTURO® Pediatric formulation

Johnson & Johnson Stops Selling Talc-Based Baby Powder In U.S. And Canada

Johnson & Johnson to Provide Webcast Fireside Chat on Clinical Data

Johnson & Johnson and AbbVie Receives 11th FDA Approval for IMBRUVICA® (ibrutinib)

New Phase IIIb Interim Data from the STARDUST Study Shows about Two-Thirds of Patients with Moderately to Severely Active Crohn’s Disease Achieved Clinical Remission...